Velicept Therapeutics
Velicept Therapeutics, a Pennsylvania-based pharmaceutical company, innovates compounds for urological and gastrointestinal treatments.
Velicept Therapeutics, a Pennsylvania-based pharmaceutical company, innovates compounds for urological and gastrointestinal treatments.
Velicept Therapeutics, founded in Pennsylvania, is a pharmaceutical company dedicated to developing novel compounds aimed at treating urological and gastrointestinal disorders. The company's core mission is to improve the quality of life for patients suffering from these conditions through innovative and effective treatments. Velicept Therapeutics focuses on creating advanced pharmaceutical solutions that address unmet medical needs in these specific areas.
Notable affiliated individuals and investors include experienced professionals in the pharmaceutical industry, though specific names are not provided. Key achievements of Velicept Therapeutics include the development and clinical testing of promising compounds that have the potential to significantly impact patient care. The company has made strides in advancing treatment options, contributing to the broader field of medical research and improving patient outcomes in urology and gastroenterology.
Companies similar to Velicept Therapeutics include Veloce BioPharma, Outpost Medicine, Valcrest Pharmaceuticals and Variant Pharmaceuticals.
Velicept Therapeutics was founded in 2015.
Velicept Therapeutics' headquarters is located in Wayne, PA, US.
Velicept Therapeutics' most recent funding round was for $6M (USD) in November 2019.
As of Nov 28, 2019, Velicept Therapeutics has disclosed funding of $42M (USD). Undisclosed round amounts are excluded.
Variant Pharmaceuticals
variantpharma.com